# New Orleans Aids Task Force

Health Center, LA
Page: https://astrelis.co/providers/health_center/191010  
This twin: https://astrelis.co/providers/health_center/191010.md  
CMS Certification Number (CCN): 191010  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2019 to 2025)

Filings that are not a full fiscal year: FY2019 covers 179 days. These years sit in no comparison pool.

- **Total patients (UDS) (FY2024):** 13,196. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total visits (all service types) (FY2024):** 53,131. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 3. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 11.2%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2025):** -1355.7%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2025):** $5.8M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2025):** +3.0%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### NO/AIDS Task Force D/B/A CrescentCare, LA

Match to this profile: matched by name (method: address and ZIP (FACLAND tier 3)).

- FY ending 2025-06-30 (audit year 2025): balance sheet foots only; audit as filed https://app.fac.gov/dissemination/summary/2025-06-GSAFAC-0000393551
- FY ending 2024-06-30 (audit year 2024): each statement foots, not linked; audit as filed https://app.fac.gov/dissemination/summary/2024-06-GSAFAC-0000344381
- FY ending 2023-06-30 (audit year 2023): balance sheet foots only; audit as filed https://app.fac.gov/dissemination/summary/2023-06-GSAFAC-0000013077

| Line | FY ending 2025-06-30 | FY ending 2024-06-30 | FY ending 2023-06-30 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 23,391,499 [derived, p.6] | 19,058,417 [derived, p.6] | 15,945,993 [derived, p.6] |
| patient receivables, net (Statement of financial position) | 900,130 [derived, p.6] | 1,153,970 [derived, p.6] | 1,337,198 [derived, p.6] |
| grants and other receivables (Statement of financial position) | 9,193,271 [derived, p.6] | 8,745,971 [derived, p.6] | 8,588,556 [derived, p.6] |
| other current assets (Statement of financial position) | 226,461 [derived, p.6] | 218,798 [derived, p.6] | 122,341 [derived, p.6] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 33,711,361 [extracted, p.6] | 29,177,156 [extracted, p.6] | 25,994,088 [extracted, p.6] |
| property and equipment, net (Statement of financial position) | 31,837,415 [derived, p.6] | 31,971,354 [derived, p.6] | 22,928,232 [derived, p.6] |
| other long-term assets (Statement of financial position) | 14,912,481 [derived, p.6] | 30,853,745 [derived, p.6] | 40,923,854 [derived, p.6] |
| TOTAL ASSETS (Statement of financial position) | 80,461,257 [extracted, p.6] | 92,002,255 [extracted, p.6] | 89,846,174 [extracted, p.6] |
| payables and accrued expenses (Statement of financial position) | 6,499,500 [derived, p.6] | 5,954,179 [derived, p.6] | 6,970,592 [derived, p.6] |
| deferred revenue (Statement of financial position) | 587,992 [derived, p.6] | absent (not printed, or not read) | absent (not printed, or not read) |
| current debt and leases (Statement of financial position) | 327,857 [derived, p.6] | 4,023,676 [derived, p.6] | 3,040,880 [derived, p.6] |
| other current liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 7,415,349 [extracted, p.6] | 9,977,855 [extracted, p.6] | 10,011,472 [extracted, p.6] |
| long-term debt and leases (Statement of financial position) | 33,176,974 [derived, p.6] | 53,563,270 [derived, p.6] | 54,257,359 [derived, p.6] |
| other long-term liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL LIABILITIES (Statement of financial position) | 40,592,323 [extracted, p.6] | 63,541,125 [extracted, p.6] | 64,268,831 [extracted, p.6] |
| net assets without donor restrictions (Statement of financial position) | 39,868,934 [derived, p.6] | 28,461,130 [derived, p.6] | 25,577,343 [derived, p.6] |
| net assets with donor restrictions (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL NET ASSETS (Statement of financial position) | 39,868,934 [extracted, p.6] | absent (not printed, or not read) | 25,577,343 [extracted, p.6] |
| patient service revenue, net (Statement of activities) | 5,898,357 [derived, p.7] | 5,019,567 [derived, p.7] | 4,991,406 [derived, p.7] |
| pharmacy and 340B revenue (Statement of activities) | 55,821,526 [derived, p.7] | 45,002,610 [derived, p.7] | 37,971,349 [derived, p.7] |
| federal grants (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other grants and contracts (Statement of activities) | 21,496,476 [derived, p.7] | 21,624,691 [derived, p.7] | 21,264,760 [derived, p.7] |
| contributions (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other revenue (Statement of activities) | 5,112,513 [derived, p.7] | 2,282,399 [derived, p.7] | 1,429,558 [derived, p.7] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 88,328,872 [extracted, p.7] | 73,929,267 [extracted, p.7] | 65,657,073 [extracted, p.7] |
| salaries and benefits (Statement of activities) | 24,898,508 [derived, p.7] | 23,507,372 [derived, p.7] | 22,018,647 [derived, p.7] |
| supplies and pharmaceuticals (Statement of activities) | 44,881,905 [derived, p.7] | 35,845,946 [derived, p.7] | 29,120,551 [derived, p.7] |
| purchased and professional services (Statement of activities) | 2,206,461 [derived, p.7] | 1,817,355 [derived, p.7] | 2,007,682 [derived, p.7] |
| occupancy (Statement of activities) | 600,174 [derived, p.7] | 743,752 [derived, p.7] | 609,957 [derived, p.7] |
| depreciation and amortization (Statement of activities) | 1,683,745 [derived, p.7] | 1,327,480 [derived, p.7] | 1,755,789 [derived, p.7] |
| interest (Statement of activities) | 1,285,302 [derived, p.7] | 1,298,183 [derived, p.7] | 977,119 [derived, p.7] |
| other expenses (Statement of activities) | 9,050,623 [derived, p.7] | 8,141,968 [derived, p.7] | 8,417,566 [derived, p.7] |
| TOTAL EXPENSES (Statement of activities) | 84,606,718 [extracted, p.7] | 72,682,056 [extracted, p.7] | 64,907,311 [extracted, p.7] |
| OPERATING RESULT (Statement of activities) | absent (not printed, or not read) | 1,247,211 [extracted, p.7] | 749,762 [extracted, p.7] |
| non-operating and other changes (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | -275,491 [derived, p.7] |
| CHANGE IN NET ASSETS (Statement of activities) | 3,722,154 [extracted, p.7] | 1,247,211 [extracted, p.7] | 474,271 [extracted, p.8] |
| net assets, beginning (Statement of activities) | 502,224 [extracted, p.8] | 27,213,919 [extracted, p.7] | absent (the total's presence could not be verified) |
| net assets, end (Statement of activities) | 39,868,934 [extracted, p.8] | 28,461,130 [extracted, p.7] | 25,577,343 [extracted, p.8] |

| Ratio | FY ending 2025-06-30 | FY ending 2024-06-30 | FY ending 2023-06-30 |
|---|---:|---:|---:|
| Days cash on hand | 103 days [plausible] | 98 days [plausible] | 92 days [plausible] |
| Current ratio | 4.55x [plausible] | 2.92x [plausible] | 2.60x [plausible] |
| Operating margin | absent [not computed] | 1.7% [plausible] | 1.1% [plausible] |
| Total margin | 4.2% [plausible] | 1.7% [plausible] | 0.7% [plausible] |
| Patient revenue share | 6.7% [plausible] | 6.8% [plausible] | 7.6% [plausible] |
| Grant dependency | absent [not computed] | absent [not computed] | absent [not computed] |
| Salaries share | 29.4% [plausible] | 32.3% [plausible] | 33.9% [plausible] |
| Days in patient receivables | 56 days [plausible] | 84 days [plausible] | 98 days [plausible] |
| Debt to net assets | 0.84x [plausible] | absent [not computed] | 2.24x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Verified). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (NO/AIDS Task Force D/B/A CrescentCare; FAC-11 template snapshot, SRC-FAC-001); the organization match is matched by name.

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "New Orleans Aids Task Force", https://astrelis.co/providers/health_center/191010, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.